Triacetoxyperiodinane → HCID 44200071, compound
Reaction equation
[OH:1][CH:2]([C:18]1[CH:23]=[CH:22][CH:21]=[CH:20][C:19]=1[CH3:24])[C:3]1[N:4]=[C:5]2[C:11]([C:12](=[O:17])[C:13]([CH3:16])([CH3:15])[CH3:14])=[CH:10][NH:9][C:6]2=[N:7][CH:8]=1.CC(OI1(OC(C)=O)(OC(C)=O)OC(=O)C2C=CC=CC1=2)=O>>[CH3:14][C:13]([CH3:16])([CH3:15])[C:12]([C:11]1[C:5]2[C:6](=[N:7][CH:8]=[C:3]([C:2](=[O:1])[C:18]3[CH:23]=[CH:22][CH:21]=[CH:20][C:19]=3[CH3:24])[N:4]=2)[NH:9][CH:10]=1)=[O:17]Participants
3
Procedure
1-[2-(Hydroxy-o-tolyl-methyl)-5H-pyrrolo[2,3-b]pyrazin-7-yl]-2,2-dimethyl-propan-1-one was treated with Dess-Martin periodinane, following general procedures described in these Examples. MP=152-154 C, (M+H)+=322.
Sources & evidence
- ORD record
- ord-dff5cff40e784a7cae179264015399b3
- Source dataset
- uspto-grants-2012_02
- Patent number
- US08119636B2
Reaction notes
Loading…